跳至内容
Enzyme inhibition in drug discovery and development : the good and the bad 線上預覽
關閉線上預覽
正在查...

Enzyme inhibition in drug discovery and development : the good and the bad

作者: Chuang Lu; A P Li
出版商: Hoboken, N.J. : Wiley, ©2010.
版本/格式:   圖書 : 英語所有版本和格式的總覽
資料庫:WorldCat
提要:
"Offering a unique approach that includes both the pharmacologic and pharmacokinetic aspects of enzyme inhibition, Enzyme Inhibition in Drug Discovery and Development examines the scientific concepts and experimental approaches related to enzyme inhibition as applied in drug discovery and drug development." "Through this focused, single-source reference on the fundamentals of drug discovery and development,  再讀一些...
評定級別:

(尚未評分) 0 附有評論 - 成爲第一個。

主題
更多類似這樣的

 

在線上查詢

與資料的連結

在圖書館查詢

&AllPage.SpinnerRetrieving; 正在查詢有此資料的圖書館...

詳細書目

資料類型: 網際網路資源
文件類型: 圖書, 網路資源
所有的作者/貢獻者: Chuang Lu; A P Li
ISBN: 9780470281741 047028174X
OCLC系統控制編碼: 318292649
描述: xiii, 854 p., [8] p. of plates : ill. (some col.) ; 25 cm.
内容: The drug discovery process / Gerald T. Miwa --
Medicinal chemistry of the optimization of enzyme inhibitors / Geraldine Harriman, Amy Elder, and Indranath Ghosh --
Bioanalytical technologies in drug discovery / Jing-Tao Wu --
Safety biomarkers in drug development : emerging trends and implications / Eric R. Fedyk --
The role of drug metabolism in drug discovery / Tonika Bohnert and Liang-Shang Gan --
Applied pharmacokinetics in drug discovery and development / Hua Yang ... [et al.] --
Enzyme inhibition and inactivation : cytochrome P450 enzymes / R. Scott Obach --
Cytochrome P450 induction / Edward L. LeCluyse ... [et al.] --
Inhibition of drug-metabolizing enzymes in gastrointestinal tract and its influence on the drug-drug interaction prediction / Aleksandra Galetin and J. Brian Houston --
Enzyme inhibition in various in vitro systems / Ping Zhao --
Cytochrome P450 degradation and its clinical relevance / Mingxiang Liao ... [et al.] --
Complexities of working with UDP-glucuronosyltransferases (UGTs) : focus on enzyme inhibition / Michael B. Fisher --
Evaluation of inhibitors of drug metabolism in human hepatocytes / Albert P. Li and Chuang Lu --
Grapefruit juice and its constituents as new esterase inhibitors / Suresh K. Balani --
Transporter-xenobiotic interactions : an important aspect of drug development studies / Gang Luo, Richard Ridgewell, and Thomas Guenthner --
Polymorphisms of drug transporters and their clinical implications / Cindy Q. Xia and Johnny J. Yang --
Clinical drug interactions due to metabolic inhibition : prediction, assessment, and interpretation / Lisa L. von Moltke and David J. Greenblatt --
Predicting interindividual variability of metabolic drug-drug interactions : identifying the causes and accounting for them using a systems approach / Amin Rostami-Hodjegan --
NF-kB : mechanism, tumor biology, and inhibitors / Lenny Dang --
G-protein-coupled receptors as drug targets / Wenyan Miao and Lijun Wu --
Pharmacological modulation of ion channels for the treatment of chronic pain / Yi Liu and Ning Qin --
Targeting the mTOR pathway for tumor therapeutics / Wei Chen --
HIV-1 protease inhibitors as antiretroviral agents / Sergei V. Gulnik, Elena Afonina, and Michael Eissenstat.
責任: edited by Chuang Lu, Albert P. Li.

摘要:

This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pharmacokinetic aspects of enzyme inhibition.  再讀一些...

評論

社評

出版商概要

"The description of each topic is clear, well organized and informative, making the book a useful or even essential high-level handbook." (ChemMedChem, November 2010)

 
讀者提供的評論
正在擷取GoodReads評論...
正在擷取DOGObooks的評論

標籤

所有的讀者標籤 (1)

檢視最熱門的標籤,呈現的形式是: 標籤我的最愛清單 | 標籤雲(tag cloud)

類似資料

確認申請

你可能已經申請過這份資料。若還是想申請,請選確認。

連結資料


<http://www.worldcat.org/oclc/318292649>
library:oclcnum"318292649"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/318292649>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:contributor
schema:contributor
schema:copyrightYear"2010"
schema:datePublished"2010"
schema:description"The drug discovery process / Gerald T. Miwa -- Medicinal chemistry of the optimization of enzyme inhibitors / Geraldine Harriman, Amy Elder, and Indranath Ghosh -- Bioanalytical technologies in drug discovery / Jing-Tao Wu -- Safety biomarkers in drug development : emerging trends and implications / Eric R. Fedyk -- The role of drug metabolism in drug discovery / Tonika Bohnert and Liang-Shang Gan -- Applied pharmacokinetics in drug discovery and development / Hua Yang ... [et al.] -- Enzyme inhibition and inactivation : cytochrome P450 enzymes / R. Scott Obach -- Cytochrome P450 induction / Edward L. LeCluyse ... [et al.] -- Inhibition of drug-metabolizing enzymes in gastrointestinal tract and its influence on the drug-drug interaction prediction / Aleksandra Galetin and J. Brian Houston -- Enzyme inhibition in various in vitro systems / Ping Zhao -- Cytochrome P450 degradation and its clinical relevance / Mingxiang Liao ... [et al.] -- Complexities of working with UDP-glucuronosyltransferases (UGTs) : focus on enzyme inhibition / Michael B. Fisher --"@en
schema:description"Evaluation of inhibitors of drug metabolism in human hepatocytes / Albert P. Li and Chuang Lu -- Grapefruit juice and its constituents as new esterase inhibitors / Suresh K. Balani -- Transporter-xenobiotic interactions : an important aspect of drug development studies / Gang Luo, Richard Ridgewell, and Thomas Guenthner -- Polymorphisms of drug transporters and their clinical implications / Cindy Q. Xia and Johnny J. Yang -- Clinical drug interactions due to metabolic inhibition : prediction, assessment, and interpretation / Lisa L. von Moltke and David J. Greenblatt -- Predicting interindividual variability of metabolic drug-drug interactions : identifying the causes and accounting for them using a systems approach / Amin Rostami-Hodjegan -- NF-kB : mechanism, tumor biology, and inhibitors / Lenny Dang -- G-protein-coupled receptors as drug targets / Wenyan Miao and Lijun Wu -- Pharmacological modulation of ion channels for the treatment of chronic pain / Yi Liu and Ning Qin -- Targeting the mTOR pathway for tumor therapeutics / Wei Chen -- HIV-1 protease inhibitors as antiretroviral agents / Sergei V. Gulnik, Elena Afonina, and Michael Eissenstat."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/795011628>
schema:inLanguage"en"
schema:name"Enzyme inhibition in drug discovery and development : the good and the bad"@en
schema:numberOfPages"854"
schema:publisher
schema:reviews
rdf:typeschema:Review
schema:itemReviewed<http://www.worldcat.org/oclc/318292649>
schema:reviewBody""Offering a unique approach that includes both the pharmacologic and pharmacokinetic aspects of enzyme inhibition, Enzyme Inhibition in Drug Discovery and Development examines the scientific concepts and experimental approaches related to enzyme inhibition as applied in drug discovery and drug development." "Through this focused, single-source reference on the fundamentals of drug discovery and development, researchers in drug metabolism and pharmacokinetics (DMPK) will learn and appreciate target biology in drug discovery; discovery biologists and medical chemists will also broaden their understanding of DMPK."--BOOK JACKET."
schema:url
schema:workExample

Content-negotiable representations

關閉視窗

請登入WorldCat 

没有帳號嗎?你可很容易的 建立免費的帳號.